Adjuvant for improving immunization effect of Edwardsiella vaccine and use method of adjuvant

A technology of immunization and adjuvant, applied in the field of immune prevention and control of Edwardsiella vaccine, to achieve the effect of improving non-specific immune protection, good application prospects and market promotion value, and enhancing immune protection

Active Publication Date: 2013-03-27
YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI
View PDF6 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The application of dextran in aquaculture is mainly used as a non-specific immune enhancer. For example, it is commonly added to shrimp feed to improve the non-specific disease resistance of prawns. It is also used as a fish feed additive to non-specifically improve fish The addition of dextran can enhance the resistance of aquatic animals to pathogens, promote growth, and improve animal performance and feed utilization. However, dextran is not currently used as an adjuvant for Edwardsiella vaccine research reports, patents or applications

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adjuvant for improving immunization effect of Edwardsiella vaccine and use method of adjuvant
  • Adjuvant for improving immunization effect of Edwardsiella vaccine and use method of adjuvant
  • Adjuvant for improving immunization effect of Edwardsiella vaccine and use method of adjuvant

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1: Determination of the safe dose of β-1,3-glucan for turbot (Scophthatmus maximus) injection

[0030] Healthy turbot (11.4 ± 1.8) g was selected, and after being temporarily raised in a cement pool for 2 weeks before the test, it was placed in a round glass fiber reinforced plastic bucket (water 0.7 m 3 ), running water culture, the water temperature is 18±2°C, the salinity is 28‰±2‰, and the aeration is continuous for 24 hours. During the test period, the compound feed was fed at 3% of the fish body weight, 3 times a day, and the water was changed and cleaned 2 times a day. Turbot was soaked and anesthetized with MS222 (1:9000) before injection.

[0031] Twenty turbot were injected intraperitoneally with β-1,3-glucan at concentrations of 2, 5, 8, 10 and 20 mg / mL, respectively, at a dose of 100 μL / tail, and observed for 14 days.

[0032] The mortality of turbot in each experimental group within 14 days is shown in Table 1. From the results, the maximum safe i...

Embodiment 2

[0035] Example 2: β-1,3-glucan was added to formalin inactivated E. tarda vaccine to immunize turbot (S. maximus).

[0036] Test fish and breeding management are the same as in Example 1.

[0037] Inoculate E. tarda 1101 in Tryptone Soy Broth (TSB), culture with shaking at 28°C overnight, then transfer to fresh TSB at a ratio of 1:100, culture with shaking at 28°C for 5 hours, collect the bacterial liquid, 6000g, 4°C, 10min, wash 3 times with sterile PBS (pH7.2), resuspend in PBS, and spread on Tryptone Soy Agar (TSA) after dilution, the bacterial count adopts the plate counting method to make 1×10 9 CFU / mL bacterial suspension, add formalin (containing 36.5-38% formaldehyde, w / v), adjust its final concentration to 1%, overnight at 4°C to make an inactivated vaccine, wash the bacteria 3 times with PBS ( The method is the same as above), and stored at 4°C. Another 0.2 mL of the inactivated bacterial solution was coated with TSA, and cultured at 28°C for 48 hours to confirm t...

Embodiment 3

[0047] Implementation Example 3: The effect of β-1,3-glucan added to formalin inactivated E. tarda vaccine to immunize turbot on serum antibody titer

[0048] Test fish and breeding management are the same as in Example 1.

[0049] Vaccine preparation preparation and test design (experimental grouping and immunization method) were the same as in Example 2. After 28 days of immunization, 0.1 mL of tail vein blood was extracted from 5 fish in each group, left at room temperature for 2 hours, and then placed at 4 ° C for 12 hours. Serum was collected, mixed with serum from fish in the same group, and stored at -20°C.

[0050] The antibody titer of the serum was determined according to the instructions of the mouse monoclonal antibody against turbot IgM (Aquatic Diagnostic Ltd, UK), and 100 μL of 1.0×10 8 cfu / mL of E. tarda 1101 suspension resuspended in the coating solution was covered and coated with 96-well ELISA plate overnight at 4°C, and then 50 μL of 0.05% (v / v) pentamethy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an adjuvant for improving the immunization effect of Edwardsiella vaccine and a use method of the adjuvant. The adjuvant is characterized by being extracted from raw materials including grain, yeast and a part of fungi or algae. The effective component of the adjuvant is beta-1,3-glucan or the natural, artificially modified or synthetic product of the beta-1,3-glucan. The adjuvant can be used for increasing the specific immune protection ratio of any one or more inculcated Edwardsiella vaccine antigens including the inactivated bacteria, the bacteria disintegration component, the less-virulent strain, the attenuated strain, the protective antigen, the antigen subunit, the antigenic determinant clusters or the expression product of the antigen cell expression vector of the Edwardsiella, can be used together or not together with the vaccine antigen and can be prepared into a single preparation which is used together with the vaccine antigen.

Description

technical field [0001] The invention relates to the immune prevention and control technology of Edwardsiella vaccine, in particular to an adjuvant capable of enhancing the immune vaccination effect of Edwardsiella vaccine and its application method. Background technique [0002] Edwardsiella sp. is one of the main pathogenic bacteria in current aquaculture, currently including Edwardsiella tarda (E. tarda), Edwardsiella catfish (E. ictaluri) and Edwardsiella sp. hoshinae) have a wide range of hosts. Infections have been reported in fish, amphibians, reptiles, birds, and mammals including humans, and they are distributed worldwide. They are commonly found in freshwater and seawater environments. Distributed in tropical and subtropical countries and regions such as China, Australia, Japan, India, Israel, the Malay Archipelago, the United States, and Panama. Since it was first reported in 1962, the pathogen has caused huge losses to a variety of fish farming industries. The u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/39A61P37/02
Inventor 黄倢谢国驷隋虎辰王秀华边慧慧史成银刘莉
Owner YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap